Boehringer Deal Leads EU Watchdog To Close Probe

The European Commission closed its probe Wednesday into claims that Boehringer Ingelheim GmbH abused the patent system to corner the multibillion-dollar market for emphysema and related lung disease treatments after the...

Already a subscriber? Click here to view full article